Global IL-17 Targeting Biological Drugs Market Growth 2026-2032
The global IL-17 Targeting Biological Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
IL-17 (interleukin-17) is an important pro-inflammatory cytokine that plays an important role in the pathological process of autoimmune diseases such as psoriasis and rheumatoid arthritis. Biological drugs targeting IL-17 reduce inflammatory responses and disease symptoms by inhibiting the activity of IL-17 or its receptors.
United States market for IL-17 Targeting Biological Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for IL-17 Targeting Biological Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for IL-17 Targeting Biological Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key IL-17 Targeting Biological Drugs players cover Chongqing Genrix Biopharmaceutical, Jiangsu Hengrui Medicine, Novartis, UCB, Eli Lilly and Co., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?IL-17 Targeting Biological Drugs Industry Forecast? looks at past sales and reviews total world IL-17 Targeting Biological Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected IL-17 Targeting Biological Drugs sales for 2026 through 2032. With IL-17 Targeting Biological Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IL-17 Targeting Biological Drugs industry.
This Insight Report provides a comprehensive analysis of the global IL-17 Targeting Biological Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on IL-17 Targeting Biological Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global IL-17 Targeting Biological Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IL-17 Targeting Biological Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IL-17 Targeting Biological Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of IL-17 Targeting Biological Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global IL-17 Targeting Biological Drugs market?
What factors are driving IL-17 Targeting Biological Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do IL-17 Targeting Biological Drugs market opportunities vary by end market size?
How does IL-17 Targeting Biological Drugs break out by Type, by Application?
IL-17 (interleukin-17) is an important pro-inflammatory cytokine that plays an important role in the pathological process of autoimmune diseases such as psoriasis and rheumatoid arthritis. Biological drugs targeting IL-17 reduce inflammatory responses and disease symptoms by inhibiting the activity of IL-17 or its receptors.
United States market for IL-17 Targeting Biological Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for IL-17 Targeting Biological Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for IL-17 Targeting Biological Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key IL-17 Targeting Biological Drugs players cover Chongqing Genrix Biopharmaceutical, Jiangsu Hengrui Medicine, Novartis, UCB, Eli Lilly and Co., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?IL-17 Targeting Biological Drugs Industry Forecast? looks at past sales and reviews total world IL-17 Targeting Biological Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected IL-17 Targeting Biological Drugs sales for 2026 through 2032. With IL-17 Targeting Biological Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IL-17 Targeting Biological Drugs industry.
This Insight Report provides a comprehensive analysis of the global IL-17 Targeting Biological Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on IL-17 Targeting Biological Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global IL-17 Targeting Biological Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IL-17 Targeting Biological Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IL-17 Targeting Biological Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of IL-17 Targeting Biological Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Oral
- Injection
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Chongqing Genrix Biopharmaceutical
- Jiangsu Hengrui Medicine
- Novartis
- UCB
- Eli Lilly and Co.
- Akesobio
- AstraZeneca
- DICE Therapeutics
What is the 10-year outlook for the global IL-17 Targeting Biological Drugs market?
What factors are driving IL-17 Targeting Biological Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do IL-17 Targeting Biological Drugs market opportunities vary by end market size?
How does IL-17 Targeting Biological Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global IL-17 Targeting Biological Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for IL-17 Targeting Biological Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for IL-17 Targeting Biological Drugs by Country/Region, 2021, 2025 & 2032
2.2 IL-17 Targeting Biological Drugs Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 IL-17 Targeting Biological Drugs Sales by Type
2.2.3.1 Global IL-17 Targeting Biological Drugs Sales Market Share by Type (2021-2026)
2.2.3.2 Global IL-17 Targeting Biological Drugs Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global IL-17 Targeting Biological Drugs Sale Price by Type (2021-2026)
2.3 IL-17 Targeting Biological Drugs Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 IL-17 Targeting Biological Drugs Sales by Application
2.3.4.1 Global IL-17 Targeting Biological Drugs Sale Market Share by Application (2021-2026)
2.3.4.2 Global IL-17 Targeting Biological Drugs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global IL-17 Targeting Biological Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global IL-17 Targeting Biological Drugs Breakdown Data by Company
3.1.1 Global IL-17 Targeting Biological Drugs Annual Sales by Company (2021-2026)
3.1.2 Global IL-17 Targeting Biological Drugs Sales Market Share by Company (2021-2026)
3.2 Global IL-17 Targeting Biological Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global IL-17 Targeting Biological Drugs Revenue by Company (2021-2026)
3.2.2 Global IL-17 Targeting Biological Drugs Revenue Market Share by Company (2021-2026)
3.3 Global IL-17 Targeting Biological Drugs Sale Price by Company
3.4 Key Manufacturers IL-17 Targeting Biological Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers IL-17 Targeting Biological Drugs Product Location Distribution
3.4.2 Players IL-17 Targeting Biological Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IL-17 TARGETING BIOLOGICAL DRUGS BY GEOGRAPHIC REGION
4.1 World Historic IL-17 Targeting Biological Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global IL-17 Targeting Biological Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global IL-17 Targeting Biological Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic IL-17 Targeting Biological Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global IL-17 Targeting Biological Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global IL-17 Targeting Biological Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas IL-17 Targeting Biological Drugs Sales Growth
4.4 APAC IL-17 Targeting Biological Drugs Sales Growth
4.5 Europe IL-17 Targeting Biological Drugs Sales Growth
4.6 Middle East & Africa IL-17 Targeting Biological Drugs Sales Growth
5 AMERICAS
5.1 Americas IL-17 Targeting Biological Drugs Sales by Country
5.1.1 Americas IL-17 Targeting Biological Drugs Sales by Country (2021-2026)
5.1.2 Americas IL-17 Targeting Biological Drugs Revenue by Country (2021-2026)
5.2 Americas IL-17 Targeting Biological Drugs Sales by Type (2021-2026)
5.3 Americas IL-17 Targeting Biological Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC IL-17 Targeting Biological Drugs Sales by Region
6.1.1 APAC IL-17 Targeting Biological Drugs Sales by Region (2021-2026)
6.1.2 APAC IL-17 Targeting Biological Drugs Revenue by Region (2021-2026)
6.2 APAC IL-17 Targeting Biological Drugs Sales by Type (2021-2026)
6.3 APAC IL-17 Targeting Biological Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe IL-17 Targeting Biological Drugs by Country
7.1.1 Europe IL-17 Targeting Biological Drugs Sales by Country (2021-2026)
7.1.2 Europe IL-17 Targeting Biological Drugs Revenue by Country (2021-2026)
7.2 Europe IL-17 Targeting Biological Drugs Sales by Type (2021-2026)
7.3 Europe IL-17 Targeting Biological Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa IL-17 Targeting Biological Drugs by Country
8.1.1 Middle East & Africa IL-17 Targeting Biological Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa IL-17 Targeting Biological Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa IL-17 Targeting Biological Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa IL-17 Targeting Biological Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of IL-17 Targeting Biological Drugs
10.3 Manufacturing Process Analysis of IL-17 Targeting Biological Drugs
10.4 Industry Chain Structure of IL-17 Targeting Biological Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 IL-17 Targeting Biological Drugs Distributors
11.3 IL-17 Targeting Biological Drugs Customer
12 WORLD FORECAST REVIEW FOR IL-17 TARGETING BIOLOGICAL DRUGS BY GEOGRAPHIC REGION
12.1 Global IL-17 Targeting Biological Drugs Market Size Forecast by Region
12.1.1 Global IL-17 Targeting Biological Drugs Forecast by Region (2027-2032)
12.1.2 Global IL-17 Targeting Biological Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global IL-17 Targeting Biological Drugs Forecast by Type (2027-2032)
12.7 Global IL-17 Targeting Biological Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Chongqing Genrix Biopharmaceutical
13.1.1 Chongqing Genrix Biopharmaceutical Company Information
13.1.2 Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Product Portfolios and Specifications
13.1.3 Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Chongqing Genrix Biopharmaceutical Main Business Overview
13.1.5 Chongqing Genrix Biopharmaceutical Latest Developments
13.2 Jiangsu Hengrui Medicine
13.2.1 Jiangsu Hengrui Medicine Company Information
13.2.2 Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Product Portfolios and Specifications
13.2.3 Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Jiangsu Hengrui Medicine Main Business Overview
13.2.5 Jiangsu Hengrui Medicine Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis IL-17 Targeting Biological Drugs Product Portfolios and Specifications
13.3.3 Novartis IL-17 Targeting Biological Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 UCB
13.4.1 UCB Company Information
13.4.2 UCB IL-17 Targeting Biological Drugs Product Portfolios and Specifications
13.4.3 UCB IL-17 Targeting Biological Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 UCB Main Business Overview
13.4.5 UCB Latest Developments
13.5 Eli Lilly and Co.
13.5.1 Eli Lilly and Co. Company Information
13.5.2 Eli Lilly and Co. IL-17 Targeting Biological Drugs Product Portfolios and Specifications
13.5.3 Eli Lilly and Co. IL-17 Targeting Biological Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Eli Lilly and Co. Main Business Overview
13.5.5 Eli Lilly and Co. Latest Developments
13.6 Akesobio
13.6.1 Akesobio Company Information
13.6.2 Akesobio IL-17 Targeting Biological Drugs Product Portfolios and Specifications
13.6.3 Akesobio IL-17 Targeting Biological Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Akesobio Main Business Overview
13.6.5 Akesobio Latest Developments
13.7 AstraZeneca
13.7.1 AstraZeneca Company Information
13.7.2 AstraZeneca IL-17 Targeting Biological Drugs Product Portfolios and Specifications
13.7.3 AstraZeneca IL-17 Targeting Biological Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 AstraZeneca Main Business Overview
13.7.5 AstraZeneca Latest Developments
13.8 DICE Therapeutics
13.8.1 DICE Therapeutics Company Information
13.8.2 DICE Therapeutics IL-17 Targeting Biological Drugs Product Portfolios and Specifications
13.8.3 DICE Therapeutics IL-17 Targeting Biological Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 DICE Therapeutics Main Business Overview
13.8.5 DICE Therapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global IL-17 Targeting Biological Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for IL-17 Targeting Biological Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for IL-17 Targeting Biological Drugs by Country/Region, 2021, 2025 & 2032
2.2 IL-17 Targeting Biological Drugs Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 IL-17 Targeting Biological Drugs Sales by Type
2.2.3.1 Global IL-17 Targeting Biological Drugs Sales Market Share by Type (2021-2026)
2.2.3.2 Global IL-17 Targeting Biological Drugs Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global IL-17 Targeting Biological Drugs Sale Price by Type (2021-2026)
2.3 IL-17 Targeting Biological Drugs Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 IL-17 Targeting Biological Drugs Sales by Application
2.3.4.1 Global IL-17 Targeting Biological Drugs Sale Market Share by Application (2021-2026)
2.3.4.2 Global IL-17 Targeting Biological Drugs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global IL-17 Targeting Biological Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global IL-17 Targeting Biological Drugs Breakdown Data by Company
3.1.1 Global IL-17 Targeting Biological Drugs Annual Sales by Company (2021-2026)
3.1.2 Global IL-17 Targeting Biological Drugs Sales Market Share by Company (2021-2026)
3.2 Global IL-17 Targeting Biological Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global IL-17 Targeting Biological Drugs Revenue by Company (2021-2026)
3.2.2 Global IL-17 Targeting Biological Drugs Revenue Market Share by Company (2021-2026)
3.3 Global IL-17 Targeting Biological Drugs Sale Price by Company
3.4 Key Manufacturers IL-17 Targeting Biological Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers IL-17 Targeting Biological Drugs Product Location Distribution
3.4.2 Players IL-17 Targeting Biological Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IL-17 TARGETING BIOLOGICAL DRUGS BY GEOGRAPHIC REGION
4.1 World Historic IL-17 Targeting Biological Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global IL-17 Targeting Biological Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global IL-17 Targeting Biological Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic IL-17 Targeting Biological Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global IL-17 Targeting Biological Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global IL-17 Targeting Biological Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas IL-17 Targeting Biological Drugs Sales Growth
4.4 APAC IL-17 Targeting Biological Drugs Sales Growth
4.5 Europe IL-17 Targeting Biological Drugs Sales Growth
4.6 Middle East & Africa IL-17 Targeting Biological Drugs Sales Growth
5 AMERICAS
5.1 Americas IL-17 Targeting Biological Drugs Sales by Country
5.1.1 Americas IL-17 Targeting Biological Drugs Sales by Country (2021-2026)
5.1.2 Americas IL-17 Targeting Biological Drugs Revenue by Country (2021-2026)
5.2 Americas IL-17 Targeting Biological Drugs Sales by Type (2021-2026)
5.3 Americas IL-17 Targeting Biological Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC IL-17 Targeting Biological Drugs Sales by Region
6.1.1 APAC IL-17 Targeting Biological Drugs Sales by Region (2021-2026)
6.1.2 APAC IL-17 Targeting Biological Drugs Revenue by Region (2021-2026)
6.2 APAC IL-17 Targeting Biological Drugs Sales by Type (2021-2026)
6.3 APAC IL-17 Targeting Biological Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe IL-17 Targeting Biological Drugs by Country
7.1.1 Europe IL-17 Targeting Biological Drugs Sales by Country (2021-2026)
7.1.2 Europe IL-17 Targeting Biological Drugs Revenue by Country (2021-2026)
7.2 Europe IL-17 Targeting Biological Drugs Sales by Type (2021-2026)
7.3 Europe IL-17 Targeting Biological Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa IL-17 Targeting Biological Drugs by Country
8.1.1 Middle East & Africa IL-17 Targeting Biological Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa IL-17 Targeting Biological Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa IL-17 Targeting Biological Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa IL-17 Targeting Biological Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of IL-17 Targeting Biological Drugs
10.3 Manufacturing Process Analysis of IL-17 Targeting Biological Drugs
10.4 Industry Chain Structure of IL-17 Targeting Biological Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 IL-17 Targeting Biological Drugs Distributors
11.3 IL-17 Targeting Biological Drugs Customer
12 WORLD FORECAST REVIEW FOR IL-17 TARGETING BIOLOGICAL DRUGS BY GEOGRAPHIC REGION
12.1 Global IL-17 Targeting Biological Drugs Market Size Forecast by Region
12.1.1 Global IL-17 Targeting Biological Drugs Forecast by Region (2027-2032)
12.1.2 Global IL-17 Targeting Biological Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global IL-17 Targeting Biological Drugs Forecast by Type (2027-2032)
12.7 Global IL-17 Targeting Biological Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Chongqing Genrix Biopharmaceutical
13.1.1 Chongqing Genrix Biopharmaceutical Company Information
13.1.2 Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Product Portfolios and Specifications
13.1.3 Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Chongqing Genrix Biopharmaceutical Main Business Overview
13.1.5 Chongqing Genrix Biopharmaceutical Latest Developments
13.2 Jiangsu Hengrui Medicine
13.2.1 Jiangsu Hengrui Medicine Company Information
13.2.2 Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Product Portfolios and Specifications
13.2.3 Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Jiangsu Hengrui Medicine Main Business Overview
13.2.5 Jiangsu Hengrui Medicine Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis IL-17 Targeting Biological Drugs Product Portfolios and Specifications
13.3.3 Novartis IL-17 Targeting Biological Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 UCB
13.4.1 UCB Company Information
13.4.2 UCB IL-17 Targeting Biological Drugs Product Portfolios and Specifications
13.4.3 UCB IL-17 Targeting Biological Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 UCB Main Business Overview
13.4.5 UCB Latest Developments
13.5 Eli Lilly and Co.
13.5.1 Eli Lilly and Co. Company Information
13.5.2 Eli Lilly and Co. IL-17 Targeting Biological Drugs Product Portfolios and Specifications
13.5.3 Eli Lilly and Co. IL-17 Targeting Biological Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Eli Lilly and Co. Main Business Overview
13.5.5 Eli Lilly and Co. Latest Developments
13.6 Akesobio
13.6.1 Akesobio Company Information
13.6.2 Akesobio IL-17 Targeting Biological Drugs Product Portfolios and Specifications
13.6.3 Akesobio IL-17 Targeting Biological Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Akesobio Main Business Overview
13.6.5 Akesobio Latest Developments
13.7 AstraZeneca
13.7.1 AstraZeneca Company Information
13.7.2 AstraZeneca IL-17 Targeting Biological Drugs Product Portfolios and Specifications
13.7.3 AstraZeneca IL-17 Targeting Biological Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 AstraZeneca Main Business Overview
13.7.5 AstraZeneca Latest Developments
13.8 DICE Therapeutics
13.8.1 DICE Therapeutics Company Information
13.8.2 DICE Therapeutics IL-17 Targeting Biological Drugs Product Portfolios and Specifications
13.8.3 DICE Therapeutics IL-17 Targeting Biological Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 DICE Therapeutics Main Business Overview
13.8.5 DICE Therapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. IL-17 Targeting Biological Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. IL-17 Targeting Biological Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injection
Table 5. Global IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (K Units)
Table 6. Global IL-17 Targeting Biological Drugs Sales Market Share by Type (2021-2026)
Table 7. Global IL-17 Targeting Biological Drugs Revenue by Type (2021-2026) & ($ million)
Table 8. Global IL-17 Targeting Biological Drugs Revenue Market Share by Type (2021-2026)
Table 9. Global IL-17 Targeting Biological Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global IL-17 Targeting Biological Drugs Sale by Application (2021-2026) & (K Units)
Table 11. Global IL-17 Targeting Biological Drugs Sale Market Share by Application (2021-2026)
Table 12. Global IL-17 Targeting Biological Drugs Revenue by Application (2021-2026) & ($ million)
Table 13. Global IL-17 Targeting Biological Drugs Revenue Market Share by Application (2021-2026)
Table 14. Global IL-17 Targeting Biological Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global IL-17 Targeting Biological Drugs Sales by Company (2021-2026) & (K Units)
Table 16. Global IL-17 Targeting Biological Drugs Sales Market Share by Company (2021-2026)
Table 17. Global IL-17 Targeting Biological Drugs Revenue by Company (2021-2026) & ($ millions)
Table 18. Global IL-17 Targeting Biological Drugs Revenue Market Share by Company (2021-2026)
Table 19. Global IL-17 Targeting Biological Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers IL-17 Targeting Biological Drugs Producing Area Distribution and Sales Area
Table 21. Players IL-17 Targeting Biological Drugs Products Offered
Table 22. IL-17 Targeting Biological Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global IL-17 Targeting Biological Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global IL-17 Targeting Biological Drugs Sales Market Share Geographic Region (2021-2026)
Table 27. Global IL-17 Targeting Biological Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global IL-17 Targeting Biological Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global IL-17 Targeting Biological Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global IL-17 Targeting Biological Drugs Sales Market Share by Country/Region (2021-2026)
Table 31. Global IL-17 Targeting Biological Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global IL-17 Targeting Biological Drugs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas IL-17 Targeting Biological Drugs Sales by Country (2021-2026) & (K Units)
Table 34. Americas IL-17 Targeting Biological Drugs Sales Market Share by Country (2021-2026)
Table 35. Americas IL-17 Targeting Biological Drugs Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (K Units)
Table 37. Americas IL-17 Targeting Biological Drugs Sales by Application (2021-2026) & (K Units)
Table 38. APAC IL-17 Targeting Biological Drugs Sales by Region (2021-2026) & (K Units)
Table 39. APAC IL-17 Targeting Biological Drugs Sales Market Share by Region (2021-2026)
Table 40. APAC IL-17 Targeting Biological Drugs Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (K Units)
Table 42. APAC IL-17 Targeting Biological Drugs Sales by Application (2021-2026) & (K Units)
Table 43. Europe IL-17 Targeting Biological Drugs Sales by Country (2021-2026) & (K Units)
Table 44. Europe IL-17 Targeting Biological Drugs Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (K Units)
Table 46. Europe IL-17 Targeting Biological Drugs Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa IL-17 Targeting Biological Drugs Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa IL-17 Targeting Biological Drugs Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa IL-17 Targeting Biological Drugs Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of IL-17 Targeting Biological Drugs
Table 52. Key Market Challenges & Risks of IL-17 Targeting Biological Drugs
Table 53. Key Industry Trends of IL-17 Targeting Biological Drugs
Table 54. IL-17 Targeting Biological Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. IL-17 Targeting Biological Drugs Distributors List
Table 57. IL-17 Targeting Biological Drugs Customer List
Table 58. Global IL-17 Targeting Biological Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global IL-17 Targeting Biological Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas IL-17 Targeting Biological Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas IL-17 Targeting Biological Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC IL-17 Targeting Biological Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC IL-17 Targeting Biological Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe IL-17 Targeting Biological Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe IL-17 Targeting Biological Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa IL-17 Targeting Biological Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa IL-17 Targeting Biological Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global IL-17 Targeting Biological Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global IL-17 Targeting Biological Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global IL-17 Targeting Biological Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global IL-17 Targeting Biological Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Chongqing Genrix Biopharmaceutical Basic Information, IL-17 Targeting Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Product Portfolios and Specifications
Table 74. Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Chongqing Genrix Biopharmaceutical Main Business
Table 76. Chongqing Genrix Biopharmaceutical Latest Developments
Table 77. Jiangsu Hengrui Medicine Basic Information, IL-17 Targeting Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Product Portfolios and Specifications
Table 79. Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Jiangsu Hengrui Medicine Main Business
Table 81. Jiangsu Hengrui Medicine Latest Developments
Table 82. Novartis Basic Information, IL-17 Targeting Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Novartis IL-17 Targeting Biological Drugs Product Portfolios and Specifications
Table 84. Novartis IL-17 Targeting Biological Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Novartis Main Business
Table 86. Novartis Latest Developments
Table 87. UCB Basic Information, IL-17 Targeting Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. UCB IL-17 Targeting Biological Drugs Product Portfolios and Specifications
Table 89. UCB IL-17 Targeting Biological Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. UCB Main Business
Table 91. UCB Latest Developments
Table 92. Eli Lilly and Co. Basic Information, IL-17 Targeting Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Eli Lilly and Co. IL-17 Targeting Biological Drugs Product Portfolios and Specifications
Table 94. Eli Lilly and Co. IL-17 Targeting Biological Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Eli Lilly and Co. Main Business
Table 96. Eli Lilly and Co. Latest Developments
Table 97. Akesobio Basic Information, IL-17 Targeting Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Akesobio IL-17 Targeting Biological Drugs Product Portfolios and Specifications
Table 99. Akesobio IL-17 Targeting Biological Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Akesobio Main Business
Table 101. Akesobio Latest Developments
Table 102. AstraZeneca Basic Information, IL-17 Targeting Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. AstraZeneca IL-17 Targeting Biological Drugs Product Portfolios and Specifications
Table 104. AstraZeneca IL-17 Targeting Biological Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. AstraZeneca Main Business
Table 106. AstraZeneca Latest Developments
Table 107. DICE Therapeutics Basic Information, IL-17 Targeting Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. DICE Therapeutics IL-17 Targeting Biological Drugs Product Portfolios and Specifications
Table 109. DICE Therapeutics IL-17 Targeting Biological Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. DICE Therapeutics Main Business
Table 111. DICE Therapeutics Latest Developments
Table 1. IL-17 Targeting Biological Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. IL-17 Targeting Biological Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injection
Table 5. Global IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (K Units)
Table 6. Global IL-17 Targeting Biological Drugs Sales Market Share by Type (2021-2026)
Table 7. Global IL-17 Targeting Biological Drugs Revenue by Type (2021-2026) & ($ million)
Table 8. Global IL-17 Targeting Biological Drugs Revenue Market Share by Type (2021-2026)
Table 9. Global IL-17 Targeting Biological Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global IL-17 Targeting Biological Drugs Sale by Application (2021-2026) & (K Units)
Table 11. Global IL-17 Targeting Biological Drugs Sale Market Share by Application (2021-2026)
Table 12. Global IL-17 Targeting Biological Drugs Revenue by Application (2021-2026) & ($ million)
Table 13. Global IL-17 Targeting Biological Drugs Revenue Market Share by Application (2021-2026)
Table 14. Global IL-17 Targeting Biological Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global IL-17 Targeting Biological Drugs Sales by Company (2021-2026) & (K Units)
Table 16. Global IL-17 Targeting Biological Drugs Sales Market Share by Company (2021-2026)
Table 17. Global IL-17 Targeting Biological Drugs Revenue by Company (2021-2026) & ($ millions)
Table 18. Global IL-17 Targeting Biological Drugs Revenue Market Share by Company (2021-2026)
Table 19. Global IL-17 Targeting Biological Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers IL-17 Targeting Biological Drugs Producing Area Distribution and Sales Area
Table 21. Players IL-17 Targeting Biological Drugs Products Offered
Table 22. IL-17 Targeting Biological Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global IL-17 Targeting Biological Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global IL-17 Targeting Biological Drugs Sales Market Share Geographic Region (2021-2026)
Table 27. Global IL-17 Targeting Biological Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global IL-17 Targeting Biological Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global IL-17 Targeting Biological Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global IL-17 Targeting Biological Drugs Sales Market Share by Country/Region (2021-2026)
Table 31. Global IL-17 Targeting Biological Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global IL-17 Targeting Biological Drugs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas IL-17 Targeting Biological Drugs Sales by Country (2021-2026) & (K Units)
Table 34. Americas IL-17 Targeting Biological Drugs Sales Market Share by Country (2021-2026)
Table 35. Americas IL-17 Targeting Biological Drugs Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (K Units)
Table 37. Americas IL-17 Targeting Biological Drugs Sales by Application (2021-2026) & (K Units)
Table 38. APAC IL-17 Targeting Biological Drugs Sales by Region (2021-2026) & (K Units)
Table 39. APAC IL-17 Targeting Biological Drugs Sales Market Share by Region (2021-2026)
Table 40. APAC IL-17 Targeting Biological Drugs Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (K Units)
Table 42. APAC IL-17 Targeting Biological Drugs Sales by Application (2021-2026) & (K Units)
Table 43. Europe IL-17 Targeting Biological Drugs Sales by Country (2021-2026) & (K Units)
Table 44. Europe IL-17 Targeting Biological Drugs Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (K Units)
Table 46. Europe IL-17 Targeting Biological Drugs Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa IL-17 Targeting Biological Drugs Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa IL-17 Targeting Biological Drugs Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa IL-17 Targeting Biological Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa IL-17 Targeting Biological Drugs Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of IL-17 Targeting Biological Drugs
Table 52. Key Market Challenges & Risks of IL-17 Targeting Biological Drugs
Table 53. Key Industry Trends of IL-17 Targeting Biological Drugs
Table 54. IL-17 Targeting Biological Drugs Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. IL-17 Targeting Biological Drugs Distributors List
Table 57. IL-17 Targeting Biological Drugs Customer List
Table 58. Global IL-17 Targeting Biological Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global IL-17 Targeting Biological Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas IL-17 Targeting Biological Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas IL-17 Targeting Biological Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC IL-17 Targeting Biological Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC IL-17 Targeting Biological Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe IL-17 Targeting Biological Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe IL-17 Targeting Biological Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa IL-17 Targeting Biological Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa IL-17 Targeting Biological Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global IL-17 Targeting Biological Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global IL-17 Targeting Biological Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global IL-17 Targeting Biological Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global IL-17 Targeting Biological Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Chongqing Genrix Biopharmaceutical Basic Information, IL-17 Targeting Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Product Portfolios and Specifications
Table 74. Chongqing Genrix Biopharmaceutical IL-17 Targeting Biological Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Chongqing Genrix Biopharmaceutical Main Business
Table 76. Chongqing Genrix Biopharmaceutical Latest Developments
Table 77. Jiangsu Hengrui Medicine Basic Information, IL-17 Targeting Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Product Portfolios and Specifications
Table 79. Jiangsu Hengrui Medicine IL-17 Targeting Biological Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Jiangsu Hengrui Medicine Main Business
Table 81. Jiangsu Hengrui Medicine Latest Developments
Table 82. Novartis Basic Information, IL-17 Targeting Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Novartis IL-17 Targeting Biological Drugs Product Portfolios and Specifications
Table 84. Novartis IL-17 Targeting Biological Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Novartis Main Business
Table 86. Novartis Latest Developments
Table 87. UCB Basic Information, IL-17 Targeting Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. UCB IL-17 Targeting Biological Drugs Product Portfolios and Specifications
Table 89. UCB IL-17 Targeting Biological Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. UCB Main Business
Table 91. UCB Latest Developments
Table 92. Eli Lilly and Co. Basic Information, IL-17 Targeting Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Eli Lilly and Co. IL-17 Targeting Biological Drugs Product Portfolios and Specifications
Table 94. Eli Lilly and Co. IL-17 Targeting Biological Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Eli Lilly and Co. Main Business
Table 96. Eli Lilly and Co. Latest Developments
Table 97. Akesobio Basic Information, IL-17 Targeting Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Akesobio IL-17 Targeting Biological Drugs Product Portfolios and Specifications
Table 99. Akesobio IL-17 Targeting Biological Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Akesobio Main Business
Table 101. Akesobio Latest Developments
Table 102. AstraZeneca Basic Information, IL-17 Targeting Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. AstraZeneca IL-17 Targeting Biological Drugs Product Portfolios and Specifications
Table 104. AstraZeneca IL-17 Targeting Biological Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. AstraZeneca Main Business
Table 106. AstraZeneca Latest Developments
Table 107. DICE Therapeutics Basic Information, IL-17 Targeting Biological Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. DICE Therapeutics IL-17 Targeting Biological Drugs Product Portfolios and Specifications
Table 109. DICE Therapeutics IL-17 Targeting Biological Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. DICE Therapeutics Main Business
Table 111. DICE Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Picture of IL-17 Targeting Biological Drugs
Figure 2. IL-17 Targeting Biological Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global IL-17 Targeting Biological Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global IL-17 Targeting Biological Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. IL-17 Targeting Biological Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. IL-17 Targeting Biological Drugs Sales Market Share by Country/Region (2025)
Figure 10. IL-17 Targeting Biological Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Oral
Figure 12. Product Picture of Injection
Figure 13. Global IL-17 Targeting Biological Drugs Sales Market Share by Type in 2026
Figure 14. Global IL-17 Targeting Biological Drugs Revenue Market Share by Type (2021-2026)
Figure 15. IL-17 Targeting Biological Drugs Consumed in Hospital
Figure 16. Global IL-17 Targeting Biological Drugs Market: Hospital (2021-2026) & (K Units)
Figure 17. IL-17 Targeting Biological Drugs Consumed in Clinic
Figure 18. Global IL-17 Targeting Biological Drugs Market: Clinic (2021-2026) & (K Units)
Figure 19. IL-17 Targeting Biological Drugs Consumed in Other
Figure 20. Global IL-17 Targeting Biological Drugs Market: Other (2021-2026) & (K Units)
Figure 21. Global IL-17 Targeting Biological Drugs Sale Market Share by Application (2025)
Figure 22. Global IL-17 Targeting Biological Drugs Revenue Market Share by Application in 2026
Figure 23. IL-17 Targeting Biological Drugs Sales by Company in 2026 (K Units)
Figure 24. Global IL-17 Targeting Biological Drugs Sales Market Share by Company in 2026
Figure 25. IL-17 Targeting Biological Drugs Revenue by Company in 2026 ($ millions)
Figure 26. Global IL-17 Targeting Biological Drugs Revenue Market Share by Company in 2026
Figure 27. Global IL-17 Targeting Biological Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global IL-17 Targeting Biological Drugs Revenue Market Share by Geographic Region in 2026
Figure 29. Americas IL-17 Targeting Biological Drugs Sales 2021-2026 (K Units)
Figure 30. Americas IL-17 Targeting Biological Drugs Revenue 2021-2026 ($ millions)
Figure 31. APAC IL-17 Targeting Biological Drugs Sales 2021-2026 (K Units)
Figure 32. APAC IL-17 Targeting Biological Drugs Revenue 2021-2026 ($ millions)
Figure 33. Europe IL-17 Targeting Biological Drugs Sales 2021-2026 (K Units)
Figure 34. Europe IL-17 Targeting Biological Drugs Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa IL-17 Targeting Biological Drugs Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa IL-17 Targeting Biological Drugs Revenue 2021-2026 ($ millions)
Figure 37. Americas IL-17 Targeting Biological Drugs Sales Market Share by Country in 2026
Figure 38. Americas IL-17 Targeting Biological Drugs Revenue Market Share by Country (2021-2026)
Figure 39. Americas IL-17 Targeting Biological Drugs Sales Market Share by Type (2021-2026)
Figure 40. Americas IL-17 Targeting Biological Drugs Sales Market Share by Application (2021-2026)
Figure 41. United States IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC IL-17 Targeting Biological Drugs Sales Market Share by Region in 2026
Figure 46. APAC IL-17 Targeting Biological Drugs Revenue Market Share by Region (2021-2026)
Figure 47. APAC IL-17 Targeting Biological Drugs Sales Market Share by Type (2021-2026)
Figure 48. APAC IL-17 Targeting Biological Drugs Sales Market Share by Application (2021-2026)
Figure 49. China IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. India IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe IL-17 Targeting Biological Drugs Sales Market Share by Country in 2026
Figure 57. Europe IL-17 Targeting Biological Drugs Revenue Market Share by Country (2021-2026)
Figure 58. Europe IL-17 Targeting Biological Drugs Sales Market Share by Type (2021-2026)
Figure 59. Europe IL-17 Targeting Biological Drugs Sales Market Share by Application (2021-2026)
Figure 60. Germany IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. France IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. UK IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa IL-17 Targeting Biological Drugs Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa IL-17 Targeting Biological Drugs Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa IL-17 Targeting Biological Drugs Sales Market Share by Application (2021-2026)
Figure 68. Egypt IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of IL-17 Targeting Biological Drugs in 2026
Figure 74. Manufacturing Process Analysis of IL-17 Targeting Biological Drugs
Figure 75. Industry Chain Structure of IL-17 Targeting Biological Drugs
Figure 76. Channels of Distribution
Figure 77. Global IL-17 Targeting Biological Drugs Sales Market Forecast by Region (2027-2032)
Figure 78. Global IL-17 Targeting Biological Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global IL-17 Targeting Biological Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global IL-17 Targeting Biological Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global IL-17 Targeting Biological Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global IL-17 Targeting Biological Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of IL-17 Targeting Biological Drugs
Figure 2. IL-17 Targeting Biological Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global IL-17 Targeting Biological Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global IL-17 Targeting Biological Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. IL-17 Targeting Biological Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. IL-17 Targeting Biological Drugs Sales Market Share by Country/Region (2025)
Figure 10. IL-17 Targeting Biological Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Oral
Figure 12. Product Picture of Injection
Figure 13. Global IL-17 Targeting Biological Drugs Sales Market Share by Type in 2026
Figure 14. Global IL-17 Targeting Biological Drugs Revenue Market Share by Type (2021-2026)
Figure 15. IL-17 Targeting Biological Drugs Consumed in Hospital
Figure 16. Global IL-17 Targeting Biological Drugs Market: Hospital (2021-2026) & (K Units)
Figure 17. IL-17 Targeting Biological Drugs Consumed in Clinic
Figure 18. Global IL-17 Targeting Biological Drugs Market: Clinic (2021-2026) & (K Units)
Figure 19. IL-17 Targeting Biological Drugs Consumed in Other
Figure 20. Global IL-17 Targeting Biological Drugs Market: Other (2021-2026) & (K Units)
Figure 21. Global IL-17 Targeting Biological Drugs Sale Market Share by Application (2025)
Figure 22. Global IL-17 Targeting Biological Drugs Revenue Market Share by Application in 2026
Figure 23. IL-17 Targeting Biological Drugs Sales by Company in 2026 (K Units)
Figure 24. Global IL-17 Targeting Biological Drugs Sales Market Share by Company in 2026
Figure 25. IL-17 Targeting Biological Drugs Revenue by Company in 2026 ($ millions)
Figure 26. Global IL-17 Targeting Biological Drugs Revenue Market Share by Company in 2026
Figure 27. Global IL-17 Targeting Biological Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global IL-17 Targeting Biological Drugs Revenue Market Share by Geographic Region in 2026
Figure 29. Americas IL-17 Targeting Biological Drugs Sales 2021-2026 (K Units)
Figure 30. Americas IL-17 Targeting Biological Drugs Revenue 2021-2026 ($ millions)
Figure 31. APAC IL-17 Targeting Biological Drugs Sales 2021-2026 (K Units)
Figure 32. APAC IL-17 Targeting Biological Drugs Revenue 2021-2026 ($ millions)
Figure 33. Europe IL-17 Targeting Biological Drugs Sales 2021-2026 (K Units)
Figure 34. Europe IL-17 Targeting Biological Drugs Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa IL-17 Targeting Biological Drugs Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa IL-17 Targeting Biological Drugs Revenue 2021-2026 ($ millions)
Figure 37. Americas IL-17 Targeting Biological Drugs Sales Market Share by Country in 2026
Figure 38. Americas IL-17 Targeting Biological Drugs Revenue Market Share by Country (2021-2026)
Figure 39. Americas IL-17 Targeting Biological Drugs Sales Market Share by Type (2021-2026)
Figure 40. Americas IL-17 Targeting Biological Drugs Sales Market Share by Application (2021-2026)
Figure 41. United States IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC IL-17 Targeting Biological Drugs Sales Market Share by Region in 2026
Figure 46. APAC IL-17 Targeting Biological Drugs Revenue Market Share by Region (2021-2026)
Figure 47. APAC IL-17 Targeting Biological Drugs Sales Market Share by Type (2021-2026)
Figure 48. APAC IL-17 Targeting Biological Drugs Sales Market Share by Application (2021-2026)
Figure 49. China IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. India IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe IL-17 Targeting Biological Drugs Sales Market Share by Country in 2026
Figure 57. Europe IL-17 Targeting Biological Drugs Revenue Market Share by Country (2021-2026)
Figure 58. Europe IL-17 Targeting Biological Drugs Sales Market Share by Type (2021-2026)
Figure 59. Europe IL-17 Targeting Biological Drugs Sales Market Share by Application (2021-2026)
Figure 60. Germany IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. France IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. UK IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa IL-17 Targeting Biological Drugs Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa IL-17 Targeting Biological Drugs Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa IL-17 Targeting Biological Drugs Sales Market Share by Application (2021-2026)
Figure 68. Egypt IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries IL-17 Targeting Biological Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of IL-17 Targeting Biological Drugs in 2026
Figure 74. Manufacturing Process Analysis of IL-17 Targeting Biological Drugs
Figure 75. Industry Chain Structure of IL-17 Targeting Biological Drugs
Figure 76. Channels of Distribution
Figure 77. Global IL-17 Targeting Biological Drugs Sales Market Forecast by Region (2027-2032)
Figure 78. Global IL-17 Targeting Biological Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global IL-17 Targeting Biological Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global IL-17 Targeting Biological Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global IL-17 Targeting Biological Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global IL-17 Targeting Biological Drugs Revenue Market Share Forecast by Application (2027-2032)
